mazindol has been researched along with Hyperglycemia, Postprandial in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angel, I | 1 |
| Taranger, MA | 1 |
1 other study available for mazindol and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Coupling between hypothalamic alpha 2-adrenoceptors and [3H]mazindol binding site in response to several hyperglycaemic stimuli in mice.
Topics: Animals; Binding Sites; Brimonidine Tartrate; Dioxanes; Feeding Behavior; Hyperglycemia; Hypothalamu | 1989 |